Back to Missouri

HB2419 • 2026

Modifies provisions relating to medication abortion

Modifies provisions relating to medication abortion

Abortion
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Loy, Cathy Jo (163)
Last action
2026-05-15
Official status
05/15/2026 - Referred: Emerging Issues(H)
Effective date
2026-08-28

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Modifies provisions relating to medication abortion

Modifies provisions relating to medication abortion

What This Bill Does

  • Modifies provisions relating to medication abortion

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-05-15 Missouri House of Representatives and Missouri Senate

    Referred: Emerging Issues(H)

  2. 2026-01-08 Missouri House of Representatives and Missouri Senate

    Read Second Time (H)

  3. 2026-01-07 Missouri House of Representatives and Missouri Senate

    Read First Time (H)

  4. 2025-12-15 Missouri House of Representatives and Missouri Senate

    Prefiled (H)

Official Summary Text

Modifies provisions relating to medication abortion

Current Bill Text

Read the full stored bill text
SECOND REGULAR SESSION
HOUSE BILL NO. 2419
103RD GENERAL ASSEMBL Y
INTRODUCED BY REPRESENT A TIVE LOY .
4363H.01I JOSEPH ENGLER, Chief Clerk
AN ACT
T o repeal section 188.021, RSMo, and to enact in lieu thereof one new section relating to
medication abortions.
Be it enacted by the General Assembly of the state of Missouri, as follows:
Section A. Section 188.021, RSMo, is repealed and one new section enacted in lieu
2 thereof, to be known as section 188.021, to read as follows:
188.021. 1. When RU-486 (mifepristone) or any drug or chemical is used for the
2 purpose of inducing an abortion, [ the initial dose ] all doses of the drug or chemical shall be
3 administered in the same room and in the physical presence of the physician who prescribed,
4 dispensed, or otherwise provided the drug or chemical to the patient. The physician inducing
5 the abortion, or a person acting on such physician's behalf, shall make all reasonable ef forts to
6 ensure that the patient returns after the administration or use of RU-486 or any drug or
7 chemical for a follow-up visit unless such termination of the pregnancy has already been
8 confirmed and the patient's medical condition has been assessed by a licensed physician prior
9 to dischar ge.
10 2. Prior to administering any drug or chemical used for the purpose of inducing
11 an abortion, the physician inducing the abortion shall:
12 (1) Perform an ultrasound to determine the gestational age of the unborn child;
13 (2) Pr ovide information to the patient on the ability of qualified medical
14 pr ofessionals to potentially r everse the effects of an abortion obtained thr ough the use of
15 abortion-inducing drugs or chemicals; and
16 (3) Pr ovide information to the patient on abortion-r eversal counseling res ources
17 including, but not limited to, instruction on how to contact the H3HELPLINE.
EXPLANA TION — Matter enclosed in bold-faced brackets [thus] in the above bill is not enacted and is
intended to be omitted from the law . Matter in bold-face type in the above bill is proposed language.
18 3. If a patient requ ests abortion-reversal medication after the administration of
19 any drug or chemical to induce an abortion, the physician shall administer such r eversal
20 medication if medically appro priate or the physician shall immediately r efer the patient
21 to another health car e provi der for the administration of such medication if medically
22 appr opriate.
23 4. The physician administering the abortion shall inform the patient of her right
24 to sepulcher under section 194.1 19 and pr ovide specific information on wher e the
25 patient may take the fetus if the fetus is deliver ed intact.
26 5. When the Food and Drug Administration label of any drug or chemical used for the
27 purpose of inducing an abortion includes any clinical study in which more than one percent of
28 those administered the drug or chemical required sur gical intervention after its administration,
29 no physician may prescribe or administer such drug or chemical to any patient without first
30 obtaining approval from the department of health and senior services of a complication plan
31 from the physician for administration of the drug or chemical to any patient. The
32 complication plan shall include any information deemed necessary by the department to
33 ensure the safety of any patient suff ering complications as a result of the administration of the
34 drug or chemical in question. No complication plan shall be required where the patient is
35 administered the drug in a medical emer gency at a hospital and is then treated as an inpatient
36 at a hospital under medical monitoring by the hospital until the abortion is completed.
37 [ 3. ] 6. The department may adopt rules, regulations, and standards governing
38 complication plans to ensure that patients underg oing abortions induced by drugs or
39 chemicals have access to safe and reliable care. Any rule or portion of a rule, as that term is
40 defined in section 536.010, that is created under the authority delegated in this section shall
41 become ef fective only if it complies with and is subject to all of the provisions of chapter 536
42 and, if applicable, section 536.028. This section and chapter 536 are nonseverable and if any
43 of the powers vested with the general assembly pursuant to chapter 536 to review , to delay the
44 ef fective date, or to disapprove and annul a rule are subsequently held unconstitutional, then
45 the grant of rulemaking authority and any rule proposed or adopted after October 24, 2017,
46 shall be invalid and void.
✔
HB 2419 2